Table 1.
Clinical characteristics, cardiovascular risk markers, and hepatic aminotransferases in obese premenopausal women (n = 48).
| Mean ± SEM | |
|---|---|
| Age (year) | 32.6 ± 2.6 |
| BMI (kg/m2) | 36.0 ± 1.6 |
| Mid-waist circumference (cm) | 102.4 ± 3.4 |
| Waist/hip ratio | 0.90 ± 0.02 |
| Total body fat (%) | 38.7 ± 1.5 |
| Trunk fat (cm2) | 141.9 ± 10.2 |
| GH Peak (ng/mL) | 10.4 ± 1.8 |
| IGF-I (ng/mL) | 147.3 ± 69.0 |
| Total cholesterol (mg/dL) | 177.1 ± 11.2 |
| HDL (mg/dL) | 52.6 ± 2.0 |
| LDL (mg/dL) | 106.3 ± 9.6 |
| Triglyceride (mg/dL) | 102.4 ± 18.3 |
| Fasting glucose (mg/dL) | 95.7 ± 2.0 |
| Fasting Insulin (μU/mL) | 13.0 ± 0.5 |
| HOMA-IR | 3.3 ± 0.5 |
| TAS | 122.5 ± 3.5 |
| TAD | 76.5 ± 3.2 |
| Leptin (ng/mL) | 24.3 ± 13.5 |
| GOT (IU/L) | 21.4 ± 8.0 |
| GPT (mIU/L) | 24.9 ± 12.7 |
| GGT (IU/L) | 25.6 ± 27.3 |